Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Study Details
Study Description
Brief Summary
The aim of the study is to examine the efficacy of ceramic water filters to reduce the burden of waterborne diarrheal illness among infants in selected villages in Kenya. In Kenya very young children are given drinking water or water is used in reconstitution of their food. We hypothesize that ceramic water filters will remove Cryptosporidium from drinking water reducing infection in infants.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Diarrhea is a major cause of illness among children in Africa. Cryptosporidium is a protozoan waterborne diarrheal pathogen resistant to chlorine. Ceramic filters are effective at improving drinking water quality, including removal of protozoa. In a recent preliminary analysis of >22,000 children <5 years enrolled in the Global Enterics Multi-Center Study (GEMS) case-control study of moderate-to-severe diarrhea, Cryptosporidium was identified as a leading cause of diarrhea in infants across all four participating African sites. This pilot is the first Cryptosporidium specific intervention trial of household ceramic water filters to reduce the burden of cryptosporidiosis acquired through drinking water in rural Kenya.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention Arm Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. |
Other: Ceramic water filter
In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends.
Other Names:
|
No Intervention: Control Arm Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. |
Outcome Measures
Primary Outcome Measures
- Longitudinal Diarrhea Prevalence [6 months]
The primary outcome measure is the longitudinal prevalence of diarrheal disease.
- Health Facility Visits for Diarrheal Disease [6 months]
incidence rate of health facility visits for diarrheal disease per 100 person-week of observation
Eligibility Criteria
Criteria
Inclusion Criteria:
Children 4-10 months old living in selected villages in the Asembo Health and Demographic Surveillance System (HDSS) study area in Kenya whose primary caretakers consent on their behalf to be visited weekly for 6 months to carry out weekly illness surveillance, and have a follow up home visit one year after initial enrollment into the trial. The household in which the child resides must be a consenting participant in the HDSS. As the children included in the trial are infants, the child's primary caretaker will be invited to participate and be administered questionnaires. Random selection will be at the compound level. Only one household per compound will be eligible for selection.
Exclusion Criteria:
Children 4-10 months old whose households are not active consenting participants in the HDSS will not be eligible for inclusion. Only the subset of children 4-10 months old who are randomly selected in the sample will be eligible for participation.
-
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kemri/Cdc | Kisumu | Kenya |
Sponsors and Collaborators
- Centers for Disease Control and Prevention
- Kenya Medical Research Institute
Investigators
- Principal Investigator: Eric Mintz, MD, MPH, Centers for Disease Control and Prevention
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CDC-NCEZID-6369
- CDCEID10A.1
- 2439
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Intervention Arm | Control Arm |
---|---|---|
Arm/Group Description | Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. |
Period Title: Overall Study | ||
STARTED | 120 | 120 |
COMPLETED | 120 | 120 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Intervention Arm | Control Arm | Total |
---|---|---|---|
Arm/Group Description | Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | Total of all reporting groups |
Overall Participants | 120 | 120 | 240 |
Age (months) [Median (Full Range) ] | |||
Median (Full Range) [months] |
7
|
8
|
7.5
|
Sex: Female, Male (Count of Participants) | |||
Female |
66
55%
|
62
51.7%
|
128
53.3%
|
Male |
54
45%
|
58
48.3%
|
112
46.7%
|
Race/Ethnicity, Customized (participants) [Number] | |||
Luo ethnic group |
120
100%
|
120
100%
|
240
100%
|
Region of Enrollment (participants) [Number] | |||
Kenya |
120
100%
|
120
100%
|
240
100%
|
Outcome Measures
Title | Longitudinal Diarrhea Prevalence |
---|---|
Description | The primary outcome measure is the longitudinal prevalence of diarrheal disease. |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
Incidence rate per 100 person-weeks of observation |
Arm/Group Title | Intervention Arm | Control Arm |
---|---|---|
Arm/Group Description | Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. |
Measure Participants | 115 | 112 |
Number [Incidence rate per 100 person-weeks] |
7.6
|
8.9
|
Title | Health Facility Visits for Diarrheal Disease |
---|---|
Description | incidence rate of health facility visits for diarrheal disease per 100 person-week of observation |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
incidence rate of health facility visits for diarrheal disease per 100 person-week of observation |
Arm/Group Title | Intervention Group | Control Group |
---|---|---|
Arm/Group Description | Intervention group who received ceramic water filters | Control Group who did not receive ceramic water filters (until after the trial ended) |
Measure Participants | 115 | 112 |
Number [incidence rate per 100 person-weeks] |
1.2
|
2.2
|
Adverse Events
Time Frame | 6 months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Intervention Arm | Control Arm | ||
Arm/Group Description | Households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water. Ceramic water filter: In total, 120 households with a child 4-10 months old will receive a Cera Maji ceramic water filter for treatment of drinking water at initial entry into the study (intervention group), and 120 households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | Households with a child 4-10 months old at initial entry into the study will not receive a ceramic water filter (control group). The study duration will be 6 months. All households in the control group will receive a Cera Maji ceramic water filter when the study ends. | ||
All Cause Mortality |
||||
Intervention Arm | Control Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 2/120 (1.7%) | 3/120 (2.5%) | ||
Serious Adverse Events |
||||
Intervention Arm | Control Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/120 (0%) | 0/120 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Intervention Arm | Control Arm | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/120 (0%) | 0/120 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Ciara O'Reilly, PhD |
---|---|
Organization | Centers for Disease Control and Prevention |
Phone | 404-639-1953 |
bwf1@cdc.gov |
- CDC-NCEZID-6369
- CDCEID10A.1
- 2439